Medivir | Evaluate

September 27, 2017

Therapy focus – mostly pain and little gain for osteoarthritis research

September 05, 2016

Odanacatib’s 15 minutes of fame

May 06, 2016

Upcoming events – Achillion combo data and Agios rare disease play

January 29, 2016

Looking for a hep C price war? Merck just started it

May 20, 2015

J&J enlivens spent hep C franchise with Achillion deal

April 09, 2015

Zero-sum hep C space awaits next-generation agents

October 23, 2014

Data in 14 has Regulus joining ranks of hep C high flyers

September 30, 2014

J&J hangs in hep C game with $1.8bn Alios takeout

August 06, 2014

Vantage point – Huge hep C costs prompt search for when and where to treat

June 11, 2014

Spotlight on Achillion as post-Sovaldi world takes shape

April 10, 2014

EASL – Merck breaks from pack with promising hep C data

Load More